Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

76 Articles

Jon C. Ogg | Sep 8, 2020 at 9:11 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

Tuesday's top analyst upgrades and downgrades include Apple, Baidu, Boeing, Delta Air Lines, L3Harris Technologies, Moderna, Raytheon Technologies, Roku and…

Jon C. Ogg | Nov 21, 2019 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AMD, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe’s, Noble Energy, PayPal, Square, Target, Virgin Galactic and More

Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe's, Noble Energy,…

Jon C. Ogg | Nov 20, 2019 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Wednesday's top analyst upgrades, downgrades and initiations include Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, Johnson & Johnson, Replimune,…

Chris Lange | Apr 8, 2019 at 11:10 AM EDT

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA…

Lee Jackson | Aug 13, 2018 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix, Papa John’s and More

The top analyst upgrades, downgrades and other research calls from Monday included Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix and…

Jon C. Ogg | Aug 7, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts…

Chris Lange | Mar 31, 2018 at 8:40 AM EDT

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial…

Jon C. Ogg | Mar 28, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Accenture, Amex, Cognizant, FireEye, Mastercard, PayPal, Verizon, Visa and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Accenture, American Expresss, Cognizant Technology Solutions, FireEye, Mastercard,…

Chris Lange | Mar 17, 2018 at 7:55 AM EDT

Even More Biopharma Catalysts Coming Through the End of March

Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates…

Chris Lange | Dec 28, 2017 at 11:50 AM EST

Top 10 Biopharma Events Kicking Off 2018

Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two…

Jon C. Ogg | Dec 18, 2017 at 11:50 AM EST

50 Mid-Cap and Larger Stocks More Than Doubled in 2017

With 2017 nearing an end, it is important to consider just what has happened. 24/7 Wall St. has screened 50…

Jon C. Ogg | Oct 30, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under…

Jon C. Ogg | Oct 2, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one…

Jon C. Ogg | Sep 27, 2017 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Axovant, Carnival, Micron, Nike, SunPower, Vivint Solar, Walgreens and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Axovant, Carnival, Micron Technology, Nike, SunPower, Vivint Solar…

Jon C. Ogg | Sep 21, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

The top analyst upgrades, downgrades and other research calls from Thursday include AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron…

1 2 3 4 … 6

Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

Top Analyst Upgrades and Downgrades: AMD, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe’s, Noble Energy, PayPal, Square, Target, Virgin Galactic and More

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Top Analyst Upgrades and Downgrades: Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix, Papa John’s and More

Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Top Analyst Upgrades and Downgrades: Accenture, Amex, Cognizant, FireEye, Mastercard, PayPal, Verizon, Visa and More

Even More Biopharma Catalysts Coming Through the End of March

Top 10 Biopharma Events Kicking Off 2018

50 Mid-Cap and Larger Stocks More Than Doubled in 2017

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

Top Analyst Upgrades and Downgrades: Axovant, Carnival, Micron, Nike, SunPower, Vivint Solar, Walgreens and More

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Alnylam Pharmaceuticals : ALNY

All Alnylam Pharmaceuticals Articles

Top Analyst Upgrades and Downgrades: Apple, Baidu, Boeing, Delta, Disney, L3Harris, Moderna, Raytheon, Roku and More

Top Analyst Upgrades and Downgrades: AMD, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe’s, Noble Energy, PayPal, Square, Target, Virgin Galactic and More

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Top Analyst Upgrades and Downgrades: Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix, Papa John’s and More

Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Top Analyst Upgrades and Downgrades: Accenture, Amex, Cognizant, FireEye, Mastercard, PayPal, Verizon, Visa and More

Even More Biopharma Catalysts Coming Through the End of March

Top 10 Biopharma Events Kicking Off 2018

50 Mid-Cap and Larger Stocks More Than Doubled in 2017

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

Top Analyst Upgrades and Downgrades: Axovant, Carnival, Micron, Nike, SunPower, Vivint Solar, Walgreens and More

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not